Actively Recruiting
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System to Treat Moderate to Severe Functional Tricuspid Regurgitation
Led by Cardiac Implants LLC · Updated on 2021-11-30
15
Participants Needed
2
Research Sites
265 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are assessing the safety and performance of the Cardiac Implants Percutaneous Ring Annuloplasty System in adults with moderate or greater functional tricuspid regurgitation FTR. This early feasibility trial aims to evaluate the transcatheter delivery and implantation of a flexible annuloplasty ring and its adjustment about 90 days later to improve heart valve function. The study also looks at changes in heart function and quality of life after treatment. The procedure involves delivering the ring through a catheter inserted via the right internal jugular vein, guided by fluoroscopy and echocardiography. After the ring is implanted and becomes embedded in heart tissue, it is manually adjusted three months later to achieve the desired valve tightening, with a fastener securing it in place. The study is single-arm and non-randomized, with all participants receiving the investigational device. Participants will undergo multiple evaluations including imaging scans, heart function tests, and quality of life assessments over several years. Safety and technical success are monitored at various time points up to five years after adjustment. The primary outcome is freedom from device or procedure-related death 30 days after the ring adjustment. Follow-up includes checks for adverse events, valve function changes, and exercise tolerance.
CONDITIONS
Brief Title
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
Research Team
N
Nodar Kipshidze, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here